James Woys - 30 Jun 2026 Form 4 Insider Report for MOLINA HEALTHCARE, INC. (MOH)

Reporting relationship: Chief Operating Officer
Issuer ticker: MOH
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 16:47:49 UTC
Prior SEC filing: 02 Mar 2026
Source filing: View source filing
Reporting owner signature: Jeff D. Barlow, by power of attorney for James Woys

Key filing fact

James Woys filed Form 4 for MOLINA HEALTHCARE, INC. (MOH) on 02 Jul 2026.

Key facts

This page summarizes James Woys's Form 4 filing for MOLINA HEALTHCARE, INC. (MOH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2026, 16:47.

Change

Previous filing in this sequence was filed on 02 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001213947 Primary reporting owner

WOYS JAMES

Relationship: Chief Operating Officer
Address: 200 OCEANGATE, SUITE 100, LONG BEACH
Signature: Jeff D. Barlow, by power of attorney for James Woys
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MOH transaction

Common Stock

Award

Transaction value
Shares: +144
Change %: +0.16%
Price: $147.51^*
Shares after: 90,178
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

Footnote F2

In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2026 of $173.54 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2026, the first date of the ESPP offering period, and (ii) June 30, 2026, the last trading day of the offering period).

Footnote F3

The shares vest as follows: 9,304 shares on March 1, 2027; 7,754 shares on March 1, 2028; and 5,672 shares on March 1, 2029. The remaining shares are vested.